Dockhorn David W 4
4 · PRA Health Sciences, Inc. · Filed Jan 2, 2018
Insider Transaction Report
Form 4
Dockhorn David W
EVP and CCO
Transactions
- Sale
Common Stock
2017-12-28$90.81/sh−68,614$6,230,837→ 4,236 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-12-28−72,850→ 12,422 totalExercise: $11.73Exp: 2023-12-20→ Common Stock (72,850 underlying) - Sale
Common Stock
2017-12-28$91.22/sh−4,236$386,408→ 0 total - Exercise/Conversion
Common Stock
2017-12-28$11.73/sh+72,850$854,531→ 72,850 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $90.16 to $91.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $91.15 to $91.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]42,636 of the options vested on March 2, 2016 upon satisfaction of certain performance criteria and 30,214 of the options vested on November 16, 2016 upon satisfaction of certain other performance criteria.